Evidence map›Paper›PMID 32121405›Full record

ArticleNutrients2020

JNK/p66Shc/ITCH Signaling Pathway Mediates Angiotensin II-induced Ferritin Degradation and Labile Iron Pool Increase.

Andżelika Borkowska, Urszula Popowska, Jan Spodnik, Anna Herman-Antosiewicz, Michał Woźniak, Jędrzej Antosiewicz

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andżelika BorkowskaDepartment of Bioenergetics and Physiology of Exercise, Medical University of Gdansk, 80-211 Gdansk, Poland.
Urszula PopowskaDepartment of Medical Chemistry, Medical University of Gdansk, 80-211 Gdansk, Poland.
Jan SpodnikDepartment of Anatomy and Neurobiology, Medical University of Gdansk, 80-211 Gdansk, Poland.
Anna Herman-AntosiewiczDepartment of Medical Biology and Genetics, University of Gdansk, 80-308 Gdansk, Poland.
Michał WoźniakDepartment of Medical Chemistry, Medical University of Gdansk, 80-211 Gdansk, Poland.
Jędrzej AntosiewiczDepartment of Bioenergetics and Physiology of Exercise, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0002-7871-6469
Gdańsk Medical University · PL

Funding

Medical University of Gdansk ST 02-0063/07/306Ministerstwo Nauki i Szkolnictwa Wyższego IP2011 004071
6 · The paper itself

Abstract

Angiotensin II (Ang II) induces deleterious changes in cellular iron metabolism and increases the generation of reactive oxygen species. This leads to an impairment of neuronal and vascular function. However, the mechanism underpinning Ang II-induced changes in iron metabolism is not known. We hypothesized that Ang II-induced ferritin degradation and an increase in the labile iron pool are mediated by the c-Jun N-terminal kinase (JNK)/p66Shc/ITCH signaling pathway. We show that Ang II treatment induced ferritin degradation in an endothelial cell lines derived from the bovine stem pulmonary artery (CPAE), human umbilical vein endothelial cells (HUVEC), and HT22 neuronal cells. Ferritin degradation was accompanied by an increase in the labile iron pool, as determined by changes in calcein fluorescence. The JNK inhibitor SP600125 abolished Ang II-induced ferritin degradation. Furthermore, the effect of Ang II on ferritin levels was completely abolished in cells transfected with vectors encoding catalytically inactive variants of JNK1 or JNK2. CPAE cells expressing inactive ITCHor p66Shc (substrates of JNK kinases) were completely resistant to Ang II-induced ferritin degradation. These observations suggest that Ang II-induced ferritin degradation and, hence, elevation of the levels of highly reactive iron, are mediated by the JNK/p66Shc/ITCH signaling pathway.

Indexed as

Angiotensin IIAnimalsCattleCell LineEndothelial CellsFerritinsHumansIronJNK Mitogen-Activated Protein KinasesMiceNeuronsProteolysisReactive Oxygen SpeciesSignal TransductionSrc Homology 2 Domain-Containing, Transforming Protein 1Ubiquitin-Protein LigasesAngiotensin IIFerritinsIronJNK Mitogen-Activated Protein KinasesReactive Oxygen SpeciesSrc Homology 2 Domain-Containing, Transforming Protein 1Ubiquitin-Protein Ligasesangiotensin IIfree radicaliron

Identifiers

PMID32121405
PMCPMC7146217
OpenAlexW3010149872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.